Biktarvy, formally known as bictegravir, is a powerful single-tablet regimen for managing HIV infection. This formula integrates three key antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It works by blocking the the viral ability to replicate within the body, remarkably decreasing the viral quantity. For many individuals,